PA Consulting Group's medical device development team will be exhibiting at the RDD Europe 2011 event in Berlin, Germany, 3-6 May 2011, with a focus on 'The future of drug delivery product development: closing the loop between treatment and patient response'.
PA Consulting Group focus on future of device development
Respiratory Drug Delivery (RDD) Europe 2011, Berlin, 3-6 May
Sarah Wren, and other PA experts in healthcare technology, will be on hand throughout the event to discuss strategy scenarios for those dealing with drug-device combination product development, including such issues as:
- how future device development will be impacted by the far reaching reforms fundamentally changing the relationships between key players across the world of healthcare
- the key drivers for the future, such as using information to create more personalised care and standardisation at the same time; thereby increasing access, driving up quality and reducing the cost of overall care
and PA will be showing concepts for future inhalation products. For a preview video please visit:
Through its global pharmaceutical and technology consultancy services, PA supports drug product development, device development, manufacturing and supply chain optimisation, commercial strategy and operations. We help organisations gain competitive advantage through all aspects of the effective delivery of new healthcare products and services
RDD Europe 2011, 3-6 May, Dorint Hotel, Berlin, Germany
For more information about PA's exhibit contact:
To find out more about PA's healthcare capability visit: http://www.paconsulting.com/futureofhealthcare
For more about PA's approach to drug delivery visit : http://www.paconsulting.com/industries/healthcare/drug-delivery/
PA Consulting Group is an innovation and transformation consultancy. We believe in the power of ingenuity to build a positive human future in a technology-driven world.